Every fourth German over the age of 60 suffers from age-related macular degeneration AMD. Statistically, the widespread disease affects half a million people, about 42,000 in the Lübeck region. AMD is not considered curable, but its course can be significantly influenced if patients react in time. A globally unique, German-Danish medical project with doctors from Lübeck, Roskilde and Køge is therefore focusing on early detection via an app. The first tests have been promising.
The German Research Foundation (DFG) and the National Natural Science Foundation of China (NSFC) promote scientific exchange and joint research projects between the University of Lübeck and the Xiàn Jiaotong University in laser nanomedicine. They approved the application of Prof. Alfred Vogel from the Institute of Biomedical Optics at the University of Lübeck and Prof. Zhenxi Zhang from the School of Life Science and Technology at Xiàn Jiaotong University and are funding a three-year mobility project with 183,000 euros.
Scientists led by the two Lübeck pharmacologists Dr. Jan Wenzel and Prof. Dr. Markus Schwaninger from the Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, have dealt with this question. In a study that has just been published in the scientific journal "Proceedings of the National Academy of Sciences (PNAS)", they investigated the effect of an increased CO2 concentration on behaviour and respiration when the blood flow in the brain is disturbed.
Prof. Dr. Sebastian Karpf from the Institute for Biomedical Optics (BMO) at the University of Lübeck has developed a novel system for LiDAR that enables fast spatial imaging in 3D. Very high speeds are achieved by using a new spectral-inertia-free scanning method. This work was done in cooperation with researchers of the University of California, Los Angeles (UCLA).
The German Research Foundation (DFG) has approved funding for a project on the genetic research of neurological movement disorders with high-throughput sequencing at the University of Lübeck. The applicants are Prof. Dr. Katja Lohmann and Prof. Dr. Christine Klein from the Institute of Neurogenetics (Department of Neurology) and Prof. Dr. Hauke Busch from the Institute of Experimental Dermatology.